Procreate

Sperm-analyzing startup raises $5M — and health-tech investments are booming

Snacks / Friday, August 09, 2019

Self-driving, AI, Internet-of-Things, VR... Fertility. The ability to have babies is a market that VC money is finally flowing into. Polina Marinova's Term Sheet captured its momentum with just 3 numbers:

  • 475: That's the total number of women in the US who froze their eggs in 2009. Out of the entire country. Four hundred and seventy five.
  • 7,300: That's how many did in 2016. Big jump.
  • $102M: And that's how much venture capitalists have invested in fertility startups so far in 2019.

Just add guys... The fertility-tech industry is now expanding to target men, too. Legacy recently raised $1.5M and mail-order sperm-testing startup Dadi just added $5M. Here's how Dadi's going full "23&Me" on the male fertility market:

  • The issue: Dadi's website says 1/2 of all fertility challenges are on the man's side.
  • The value prop: Order the $99 kit and send back a sample. They'll evaluate your fertility percentile and suggest lifestyle changes to up the likelihood you'll be able to conceive.
  • The revenues: One-time sales are nice, but how do they get recurring money out of this? Subscriptions — $9.99/month keeps the sperm frozen as you age, so it's ready when you are.

"Brand-icorns" are emerging in health-tech... Not unicorns. Brand-icorns. Casper, Allbirds, or Away = digital-first startups that focus on branding, cut out middlemen, and hit $1B valuations. Now health-tech could lead the next wave of direct-to-consumer Brand-icorns. Balding and erectile dysfunction startup Roman is worth half-a-billion and rival Hims just passed the billion mark. Fertility could be up next.

Get Your News

Subscribe and thrive

Snacks provides fresh takes on the financial news you need to start your day. Chartr provides data visualizations on business, entertainment, and society. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.